<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药时代 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-06T20:30:10+08:00</updated>
  <subtitle>欢迎您走进药时代！这是一个千载难逢的医药研发新时代！我们分享最新的有价值的行业资讯，讲述医药背后感人的故事，举办形式多样、内容丰富的线上线下活动，与朋友们一起学习成长，将新药研发事业进行到底，让新药带给世界更多更大的健康</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>专栏 | ​浅谈药品开发中PAR/NOR的确定</title>
    <updated>2020-11-05T08:53:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/z0qbZvSTZOo69_Aw2e-urg</id>
    <link href="https://mp.weixin.qq.com/s/z0qbZvSTZOo69_Aw2e-urg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>实体肿瘤新突破！Selinexor用于脂肪肉瘤III期临床研究达到主要终点</title>
    <updated>2020-11-05T08:53:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/lHgYhbGBosnmOMoKtSePDA</id>
    <link href="https://mp.weixin.qq.com/s/lHgYhbGBosnmOMoKtSePDA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>美国顶级生物技术风投如何孵化AI药物研发组合：大小分子药物两手抓，但数据质量仍是最大掣肘</title>
    <updated>2020-11-05T08:53:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/3h5nAhqMXBSy9kq7a3-dcw</id>
    <link href="https://mp.weixin.qq.com/s/3h5nAhqMXBSy9kq7a3-dcw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“研发英雄” 群雄逐鹿，2020勃林格殷格翰创新大赛中国创新冠军诞生</title>
    <updated>2020-11-04T11:30:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/lO-Fqs9Bv5Ze2S-qiqST5A</id>
    <link href="https://mp.weixin.qq.com/s/lO-Fqs9Bv5Ze2S-qiqST5A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>专栏｜根本原因分析法（RCA），让制剂开发更高效！！！</title>
    <updated>2020-11-04T11:30:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/tmxyo8HBCa3GisfiLuh9ZA</id>
    <link href="https://mp.weixin.qq.com/s/tmxyo8HBCa3GisfiLuh9ZA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>现场直击 | 硬核干货、精美礼品全都有！2020中国新药CMC高峰论坛盛大开幕！</title>
    <updated>2020-11-04T11:30:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/uxWHBPnF1YBuJiDpJ40IZg</id>
    <link href="https://mp.weixin.qq.com/s/uxWHBPnF1YBuJiDpJ40IZg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全面解读：从A股、港股、美股看生物医药企业的研发投入</title>
    <updated>2020-11-04T11:30:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/cZsvBra6WRb86w0Sjunyjg</id>
    <link href="https://mp.weixin.qq.com/s/cZsvBra6WRb86w0Sjunyjg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>跨国药企和创新研究中心的首次“跨界联手”：共享创新平台，碰撞科研火花 ——BI-ATLATL联合创新实验室正式启用</title>
    <updated>2020-11-03T19:10:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/xn-q4_muVWxJGsIcLrC4og</id>
    <link href="https://mp.weixin.qq.com/s/xn-q4_muVWxJGsIcLrC4og" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Aducanumab营销授权申请获EMA受理，不知能否顺利通过FDA审查会议</title>
    <updated>2020-11-03T19:10:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/DQ128gFEF7vXfC855vdwdQ</id>
    <link href="https://mp.weixin.qq.com/s/DQ128gFEF7vXfC855vdwdQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>博腾生物基因与细胞治疗CDMO平台启动，携手BioBAY，共促产业发展！</title>
    <updated>2020-11-03T19:10:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/SJkaF2KA26dgFmpWJuBfxQ</id>
    <link href="https://mp.weixin.qq.com/s/SJkaF2KA26dgFmpWJuBfxQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>拍了拍你，并悄悄告你：2020中国新药CMC高峰论坛有直播啦！</title>
    <updated>2020-11-03T19:10:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/oY4gtkB8kNjwG7nrGOoR2A</id>
    <link href="https://mp.weixin.qq.com/s/oY4gtkB8kNjwG7nrGOoR2A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>博腾药时代直播间｜通过系统化思维考虑数据完整性</title>
    <updated>2020-11-03T19:10:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/WpFP6qOPqVx-e1F0b_EqnQ</id>
    <link href="https://mp.weixin.qq.com/s/WpFP6qOPqVx-e1F0b_EqnQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>喜迎进博会！罗家立、陈力博士等专家畅谈创新与转型</title>
    <updated>2020-11-01T21:57:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-01:/s/N-UYM7aXitFpXtdR-HoCnA</id>
    <link href="https://mp.weixin.qq.com/s/N-UYM7aXitFpXtdR-HoCnA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>专栏｜设计空间：制剂研发人员使用QbD的终极目标（下）</title>
    <updated>2020-11-01T21:57:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-01:/s/gZgvlozaM8xqlGgDCXP0Yw</id>
    <link href="https://mp.weixin.qq.com/s/gZgvlozaM8xqlGgDCXP0Yw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>数十家跨国药企围猎NTRK激酶抑制剂！谁是王者？</title>
    <updated>2020-11-01T21:57:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-01:/s/iMDg1fmUHCouLTvFoVdKLg</id>
    <link href="https://mp.weixin.qq.com/s/iMDg1fmUHCouLTvFoVdKLg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>千人盛会，欢聚张江！2020中国新药CMC高峰论坛温馨提示</title>
    <updated>2020-11-01T21:57:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-01:/s/e0EEl3MbXWTObdwdS3bV5g</id>
    <link href="https://mp.weixin.qq.com/s/e0EEl3MbXWTObdwdS3bV5g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药明直播间|药物分析系列(三)：浅谈分子成药性质</title>
    <updated>2020-11-01T21:57:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-01:/s/TCR2L1ql7syG2l5V9i2rhw</id>
    <link href="https://mp.weixin.qq.com/s/TCR2L1ql7syG2l5V9i2rhw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>专栏｜设计空间：制剂研发人员使用QbD的终极目标（上）</title>
    <updated>2020-11-01T09:13:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-01:/s/u40rTsixLTYd6lSoBTsF_g</id>
    <link href="https://mp.weixin.qq.com/s/u40rTsixLTYd6lSoBTsF_g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>赛诺菲/默沙东、Arcus/阿斯利康同日达成两项免疫组合疗法全新合作</title>
    <updated>2020-11-01T09:13:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-01:/s/84wRkQPNif68rMZssdv27Q</id>
    <link href="https://mp.weixin.qq.com/s/84wRkQPNif68rMZssdv27Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Semorinemab的失败，却重挫了Tau的希望？</title>
    <updated>2020-11-01T09:13:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-01:/s/S0BxWgOtpAEBSyCsf7UvDQ</id>
    <link href="https://mp.weixin.qq.com/s/S0BxWgOtpAEBSyCsf7UvDQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>